Medical Education Grants

Alkermes Medical Education Grants

Click Here to Apply

Alkermes contributes to independent education by supporting medical education grants. Our focus areas include educational activities with pragmatic approaches to improve patient care and public health in the domains of schizophrenia, bipolar disorder, opioid use disorder, and alcohol use disorder. We expect to contribute to an improved understanding of the underlying mechanisms of disease and their relevance to currently approved and emerging medications that address those characteristics, as well as psychosocial interventions.

Medical education grant funding is available for medical education activities, including live, print, enduring, and/or web-based activities. Examples of educational requests include, but are not limited to:

  • Accredited Continuing Education: Educational programs for healthcare providers such as physicians, nurses, and/or pharmacists that provide continuing education credits.
  • Non-Accredited Professional Educational Activities: Educational programs for healthcare providers such as physicians, nurses, and pharmacists that do not provide continuing education credits.

Who May Apply

Only US-based organizations may apply. Medical Education Grants may be awarded to (i) organizations qualified as nonprofit with tax exempt status under the U.S. Internal Revenue Code or (ii) for-profit organizations that are accredited continuing medical education providers.

How to Apply

Requests must be submitted online by the educational provider. Submissions are due at least 90 days in advance of the activity date.

Click Here to Apply


Request For Proposal: COVID-19: Serious Mental Illness/Addiction (RFP# 2020-RFP-COVID-19)

  • Alkermes is interested in funding independent medical educational programs regarding best practices in caring for patients with diagnoses of schizophrenia, bipolar disorder, opioid use disorder, or alcohol use disorder during the novel coronavirus (COVID-19) pandemic.
  • Priority will be given to programs that develop web-based and/or enduring materials including topics of:
    • Innovative uses of technology (e.g. telepsychiatry, smartphones, apps) to facilitate communication between healthcare providers, caregivers and patients
    • Initiating and/or maintaining pharmacotherapy, including Long Acting Injectables (LAIs)
  • Priority will also be given to programs that can launch quickly given the severity and rapidly evolving nature of the current COVID-19 situation.
    • In order to facilitate rapid execution of educational programs, the previous requirement that applications must be submitted at least 90 days in advance has been waived.
  • Educational activities must be accredited (CME/CE), and collaborations between medical societies, academic institutions, and medical education companies are encouraged.
  • Target audiences for this education include physicians, nurse practitioners, physician assistants and pharmacists.
  • Budget: There is no pre-specified limit on the amount of money that may be requested for an educational program under this RFP. However, the total cost of a proposed program will be taken into consideration by the review committee.
  • Requests must be submitted online by the accredited provider.
  • Proposals must be submitted to our online portal between the dates May 1st – May 15th, 2020. Any proposal submitted after this period will not be eligible for RFP consideration. Please reference RFP number RFP# 2020-RFP-COVID-19 when applying online.
  • Recipients will be selected by the Alkermes Grant Review Committee, and recipients will be notified by end of May 2020.

Request For Proposal: Alcohol Use Disorder (RFP# 2020-RFP-AUD-01)

Click here for PDF Postcard

  • Alkermes is looking to fund independent medical educational programs regarding best practices for the use of medications for the treatment of alcohol use disorder, including best practices around initiating these medications in real-world settings and maintaining medication adherence to improve outcomes in patients.
  • Priority will be given to programs that develop enduring materials and that identify best practices based on the consensus view of experts in the fields of alcohol use disorder research and clinical practice.
  • Education activities must be accredited (CME/CE), and collaborations between medical societies, academic institutions, and medical education companies are encouraged.
  • Target audiences for this education include addiction care teams, including physicians, nurse practitioners, physician assistants and pharmacists.
  • Budget: There is no pre-specified limit on the amount of money that may be requested for an educational program under this RFP. However, the total cost of a proposed program will be taken into consideration by the review committee. Requests with multiple funding sources are preferred.
  • Requests must be submitted online by the accredited provider. Submissions are due at least 90 days in advance of the activity date.
  • Proposals must be submitted to our online portal between the dates April 1, 2020 – May 15, 2020. Any proposal submitted before or after this window period will not be eligible for RFP consideration. Please reference RFP number RFP# 2020-RFP-AUD-01 when applying online.
  • Recipients will be selected by the Alkermes Grant Review Committee, and recipients will be notified in June 2020.

Areas of Interest for Medical Education Requests

  • Alkermes is interested in collaborative submissions between CME providers partnering with professional organizations of practitioners who focus on treatment of persons with schizophrenia, bipolar disorder, alcohol use disorder, or opioid use disorder.
  • Examples might include proposals for CME activities for regional meetings of psychiatric or addiction practitioners, or partnering with advanced practice nurse, case manager, or pharmacist societies in their CME efforts for their constituents.

Alkermes is currently accepting proposals that address the topic areas listed below.

Alcohol Use Disorder

  • Increasing awareness and understanding of alcohol use disorder (AUD), medication treatment options and treatment guidelines
  • Reducing barriers to treatment initiation for patients with AUD
  • Exploring factors that influence and improve retention in treatment for patients with AUD
  • Integrating medication for the treatment of AUD into outpatient practice

Opioid Use Disorder

  • Increasing awareness and understanding of opioid use disorder (OUD), medication treatment options and treatment guidelines
  • Reducing barriers to initiation of treatment for patients with OUD
  • Exploring factors that influence and improve retention in treatment for patients with OUD
  • Improving the awareness and understanding of long-acting injectable medications for the treatment of OUD
  • Improving the understanding of comparative effectiveness data for the treatment of OUD

Schizophrenia

  • Understanding and implementing pharmacologic approaches to address one or more of the following challenges in the treatment of schizophrenia:
    • suboptimal therapeutic response
    • gaps in medication adherence
    • side effects associated with treatment
  • Emerging pharmacologic approaches and their mechanism of action for the treatment of schizophrenia
  • Using patient-centered approaches to optimize treatment of schizophrenia

Bipolar Disorder

  • Understanding and implementing pharmacologic approaches to address one or more of the following challenges in the treatment of bipolar disorder:
    • suboptimal therapeutic response
    • gaps in medication adherence
    • side effects associated with treatment
  • Emerging pharmacologic approaches and their mechanisms of action for the treatment of bipolar disorder
  • Using patient-centered approaches to optimize treatment of bipolar disorder

Application Requirements

Grant requests must be submitted at least 90 days prior to the activity start date. NOTE: This requirement has been waived for the COVID-19 RFP. The following information is required for application submissions:

  • Grant Letter of Request
  • Activity Agenda
  • Activity Detailed Budget
  • Needs Assessment with references
  • Learning Objectives
  • Educational Outcomes Plan
  • Activity Description, including location of activity if relevant
  • Honoraria if applicable, including hourly rate and number of hours to be worked
  • Firewall policy if applicable
  • W9 form (current)
  • Accreditation Certificate(s)

Key Considerations

  • Alkermes’ educational grant funds may not be used to support overhead expenses of the applicant or for any other institution affiliated with the applicant.
  • Grant requests must be unsolicited and should typically have multiple funders.
  • Grants must support education on a wide range of treatment options, not promote a particular medicine and must not provide nor promise to Alkermes any tangible benefit.
  • If there will be faculty for the activity, please do not share faculty names with Alkermes in any of the documentation uploaded.
  • If requesting honoraria payment for faculty, please include in your submission the hourly rate and anticipated number of hours to be worked.
  • Alkermes will not support funding for meals, unless they are modest buffet meals, snacks or coffee that are made available to all attendees of the Educational Activity and where the identity of the Healthcare Participants who partake is not separately identifiable.
  • Alkermes does not provide unrestricted educational grants; its grant funds are intended to be used for the purpose defined within the original request.

Educational grants will not be awarded to or for:

  • Individuals or a healthcare professional’s private practice
  • Any charity or foundation associated with or controlled by an individual healthcare professional or healthcare professional’s private practice
  • Organizations that discriminate on the basis of race, color, sex, sexual orientation, religion, age, national origin or disability
  • Fundraising event of a potential customer (e.g., treatment center or hospital) where the proceeds are being used to cover general operational and routine business costs
  • Events that have already occurred
  • Political organizations, campaigns and activities
  • Religious organizations or groups whose activities are primarily sectarian in purpose
  • Programs or proposals that supplement an organization’s income or offset its expenses in a manner that benefits, directly or indirectly, a physician’s compensation

Alkermes is committed to complying with all applicable regulations and codes pertaining to education grants. Alkermes follows the requirements of the Compliance Program Guidance for Pharmaceutical Manufacturers issued by the Department of Health and Human Services Office of the Inspector General (“OIG Guidelines”), the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals (“PhRMA Code”), the FDA Guidance to Industry Supported Scientific and Educational Activities, and the Accreditation Council for Continuing Medical Education (“ACCME”) Standards for Commercial Support. Alkermes does not provide support for education programs that are intended to encourage, induce, or influence any grant recipient to purchase, prescribe, refer, recommend, sell, administer, or arrange for the purchase, sale or recommendation, or formulary placement of any Alkermes product.

Questions

Please contact: Med.Ed@alkermes.com

To submit an educational grant request, please register and submit your completed application and supporting documentation through Alkermes’ medical education grant management system located here.